Strategic CDMO Novocol Pharma operates as a sterile injectable cartridge-focused CDMO with capabilities spanning process scale up, development, analytical services, technology transfer, and both biologic and small molecule manufacturing, presenting a comprehensive outsourcing partner for pharma and biotech companies seeking end-to-end fill-finish solutions.

Moderna Partnership Recent high-profile collaboration with Moderna for aseptic fill-finish, labeling and packaging of mRNA respiratory vaccines signals strong validation of capabilities and opens door for similar large-scale, regulated mRNA or high-value biologic programs.

Global Regulatory Global regulatory approvals across USA, Canada, Europe, Middle East and Asia indicate readiness to support international supply, enabling sales opportunities with multinational sponsors seeking compliant, cross-border CDMO solutions.

Delivery Device Synergy Affiliation with Duoject Medical Systems for innovative drug delivery devices enhances value proposition for combination products, enabling bundled services from formulation to device integration that can attract clients pursuing combination therapy and patient-centric delivery.

Growth & Scale Revenue range and employee scale, combined with modern facilities and a 40+ year track record, position Novocol as a stable, scalable partner capable of handling high mix, high compliance projects for mid- to large-cap sponsors seeking reliable manufacturing capacity.